Neuropace Inc
NASDAQ:NPCE

Watchlist Manager
Neuropace Inc Logo
Neuropace Inc
NASDAQ:NPCE
Watchlist
Price: 13.01 USD -3.91% Market Closed
Market Cap: 423.6m USD

During the last 3 months Neuropace Inc insiders have not bought any shares, and sold 50.7m USD worth of shares. The stock price has increased by 9% over this period (open performance analysis).

The last transaction was made on Feb 21, 2025 by Morrell Martha (Chief Medical Officer) , who sold 1.1m USD worth of NPCE shares.

Last Transactions:
Morrell Martha
Chief Medical Officer
$-1.1m
Kck Ltd.
Chief Financial Officer (CFO)
$-49.5m
Morrell Martha
$-3k
Morrell Martha
Chief Medical Officer
$-48k
Kck Ltd.
Chief Financial Officer (CFO)
$-1.2m
Kck Ltd.
Chief Financial Officer (CFO)
$-24.9k
Kck Ltd.
Chief Financial Officer (CFO)
$-30.7k
Kck Ltd.
Chief Financial Officer (CFO)
$-23.1k
Kck Ltd.
Chief Financial Officer (CFO)
$-33.5k
Orbimed Advisors Llc
$-220k
Orbimed Advisors Llc
Investor
$-25k
Orbimed Advisors Llc
Investor
$-255.9k
Orbimed Advisors Llc
Investor
$-197.1k
Orbimed Advisors Llc
Investor
$-6.7m
Morrell Martha
Chief Medical Officer
$-213.1k
Morrell Martha
Chief Medical Officer
$-170k
Morrell Martha
Chief Medical Officer
$-12.4k
Morrell Martha
Chief Medical Officer
$-1k
Morrell Martha
Chief Medical Officer
$-27.7k
Morrell Martha
Chief Medical Officer
$-89.8k
Kck Ltd.
Chief Financial Officer (CFO)
$-49.2k
Kck Ltd.
Chief Financial Officer (CFO)
$-58.2k
Orbimed Advisors Llc
Investor
$-69.1k
Accelmed Partners Ii L.p.
$+491.5k
Ridley Irina
Chief Executive Officer
$-14.4k
Ridley Irina
Chief Executive Officer
$-11.1k
Ridley Irina
Chief Executive Officer
$+40k
Accelmed Partners Ii L.p.
Director
$+10m
Garfield Greg Shaw
Chief Financial Officer (CFO)
$+225k
Norton Evan
Chief Financial Officer
$+10m
Orbimed Advisors Llc
Investor
$+4m
Fischer Frank M
Chief Financial Officer
$+850k
View All Transactions

During the last 3 months Neuropace Inc insiders have not bought any shares, and sold 50.7m USD worth of shares. The stock price has increased by 9% over this period (open performance analysis).

The last transaction was made on Feb 21, 2025 by Morrell Martha (Chief Medical Officer) , who sold 1.1m USD worth of NPCE shares.

Sold
0-3
months
50.7m USD
2
3-6
months
1.3m USD
1
6-9
months
56.6k USD
1
9-12
months
7.4m USD
1
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD

Neuropace Inc
Insider Trading Chart

Neuropace Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Neuropace Inc
Last Insider Transactions

Global
Insiders Monitor

Neuropace Inc
Glance View

Market Cap
392.2m USD
Industry
Health Care

NeuroPace, Inc. develops, manufactures and markets implantable devices for treating epilepsy and neurological disorders. The company is headquartered in Mountain View, California. The company went IPO on 2021-04-22. The firm is focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company’s novel and differentiated RNS System is the brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source. The Company’s RNS System is a platform that delivers care for patients suffering from drug-resistant epilepsy and offers a personalized solution and outcomes to the patients suffering from other brain disorders. RNS System is a device that records brain activity data and clinicians to monitor patients. RNS System monitors the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is engaged in treating other brain disorders including depression, impulse control disorders, memory disorders, and post-traumatic stress.

NPCE Intrinsic Value
11.45 USD
Overvaluation 12%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top